

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 9.30800401 |
| 2 | negative regulation of macroautophagy (GO:0016242) | 9.21452604 |
| 3 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 7.67650653 |
| 4 | energy homeostasis (GO:0097009) | 6.13907357 |
| 5 | sulfate transmembrane transport (GO:1902358) | 6.00929199 |
| 6 | complement activation, alternative pathway (GO:0006957) | 5.90996375 |
| 7 | cellular anion homeostasis (GO:0030002) | 5.89800916 |
| 8 | detection of external biotic stimulus (GO:0098581) | 5.82938196 |
| 9 | negative regulation of meiosis (GO:0045835) | 5.60165737 |
| 10 | phosphate ion homeostasis (GO:0055062) | 5.55592781 |
| 11 | trivalent inorganic anion homeostasis (GO:0072506) | 5.55592781 |
| 12 | regulation of apoptotic cell clearance (GO:2000425) | 5.19219666 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.04832051 |
| 14 | sulfate transport (GO:0008272) | 4.99022780 |
| 15 | lateral ventricle development (GO:0021670) | 4.98838797 |
| 16 | positive regulation of neurological system process (GO:0031646) | 4.93081854 |
| 17 | detection of biotic stimulus (GO:0009595) | 4.91692624 |
| 18 | regulation of protein activation cascade (GO:2000257) | 4.86296854 |
| 19 | regulation of complement activation (GO:0030449) | 4.80337676 |
| 20 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.75721368 |
| 21 | glucocorticoid biosynthetic process (GO:0006704) | 4.64662246 |
| 22 | exogenous drug catabolic process (GO:0042738) | 4.64308469 |
| 23 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.53842950 |
| 24 | cholesterol efflux (GO:0033344) | 4.34868894 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.34303684 |
| 26 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.29713414 |
| 27 | neuron remodeling (GO:0016322) | 4.29125613 |
| 28 | glycoside metabolic process (GO:0016137) | 4.28738689 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 4.19134514 |
| 30 | negative regulation of response to nutrient levels (GO:0032108) | 4.17219897 |
| 31 | negative regulation of response to extracellular stimulus (GO:0032105) | 4.17219897 |
| 32 | bicarbonate transport (GO:0015701) | 4.17021439 |
| 33 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.11855781 |
| 34 | peptidyl-lysine dimethylation (GO:0018027) | 4.11317662 |
| 35 | phospholipid efflux (GO:0033700) | 4.06553121 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.03248193 |
| 37 | plasma lipoprotein particle assembly (GO:0034377) | 4.02488829 |
| 38 | estrogen biosynthetic process (GO:0006703) | 4.02212189 |
| 39 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.98731830 |
| 40 | negative regulation of sterol transport (GO:0032372) | 3.98125027 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 3.98125027 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.90874723 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.90384133 |
| 44 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.86194567 |
| 45 | protein-lipid complex assembly (GO:0065005) | 3.84416136 |
| 46 | regulation of macrophage chemotaxis (GO:0010758) | 3.81570273 |
| 47 | low-density lipoprotein particle remodeling (GO:0034374) | 3.80697625 |
| 48 | drug catabolic process (GO:0042737) | 3.76024932 |
| 49 | sulfur compound transport (GO:0072348) | 3.75774354 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 3.69535421 |
| 51 | macromolecular complex remodeling (GO:0034367) | 3.69535421 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.69535421 |
| 53 | complement activation, classical pathway (GO:0006958) | 3.67290399 |
| 54 | negative regulation of glial cell proliferation (GO:0060253) | 3.64552141 |
| 55 | complement activation (GO:0006956) | 3.51864469 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.51753019 |
| 57 | inositol metabolic process (GO:0006020) | 3.49816087 |
| 58 | oligosaccharide catabolic process (GO:0009313) | 3.47753704 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47638541 |
| 60 | protein activation cascade (GO:0072376) | 3.45681711 |
| 61 | plasma lipoprotein particle organization (GO:0071827) | 3.44070678 |
| 62 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.43431494 |
| 63 | L-phenylalanine catabolic process (GO:0006559) | 3.41633937 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.41633937 |
| 65 | epoxygenase P450 pathway (GO:0019373) | 3.39708905 |
| 66 | prostate gland growth (GO:0060736) | 3.37897908 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.37893225 |
| 68 | L-phenylalanine metabolic process (GO:0006558) | 3.37893225 |
| 69 | protein-lipid complex subunit organization (GO:0071825) | 3.37753340 |
| 70 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.32544419 |
| 71 | glucocorticoid metabolic process (GO:0008211) | 3.31462758 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.30474094 |
| 73 | protein carboxylation (GO:0018214) | 3.30474094 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27370823 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27370823 |
| 76 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25388116 |
| 77 | positive regulation of phagocytosis (GO:0050766) | 3.24497176 |
| 78 | positive regulation of vascular permeability (GO:0043117) | 3.24237471 |
| 79 | negative regulation of meiotic cell cycle (GO:0051447) | 3.22741887 |
| 80 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.19132725 |
| 81 | regulation of cholesterol storage (GO:0010885) | 3.18415650 |
| 82 | regulation of humoral immune response (GO:0002920) | 3.16439034 |
| 83 | N-acetylneuraminate metabolic process (GO:0006054) | 3.16291989 |
| 84 | positive regulation of glycolytic process (GO:0045821) | 3.13656505 |
| 85 | positive regulation of steroid metabolic process (GO:0045940) | 3.12911170 |
| 86 | glycosphingolipid catabolic process (GO:0046479) | 3.12765102 |
| 87 | acute-phase response (GO:0006953) | 3.09667722 |
| 88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.08696163 |
| 89 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.06190449 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 3.05366729 |
| 91 | regulation of mononuclear cell migration (GO:0071675) | 3.05248888 |
| 92 | fibrinolysis (GO:0042730) | 3.04452965 |
| 93 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.04320454 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 3.04297717 |
| 95 | omega-hydroxylase P450 pathway (GO:0097267) | 3.00517989 |
| 96 | diaphragm development (GO:0060539) | 3.00162814 |
| 97 | polyketide metabolic process (GO:0030638) | 24.4649862 |
| 98 | doxorubicin metabolic process (GO:0044598) | 24.4649862 |
| 99 | daunorubicin metabolic process (GO:0044597) | 24.4649862 |
| 100 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.97101127 |
| 101 | bile acid biosynthetic process (GO:0006699) | 2.94566002 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 2.92426686 |
| 103 | androgen biosynthetic process (GO:0006702) | 2.89296388 |
| 104 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.88586026 |
| 105 | cholesterol transport (GO:0030301) | 2.88473595 |
| 106 | sterol transport (GO:0015918) | 2.88473595 |
| 107 | lipoprotein metabolic process (GO:0042157) | 2.88298583 |
| 108 | tachykinin receptor signaling pathway (GO:0007217) | 2.87099812 |
| 109 | negative regulation of hemostasis (GO:1900047) | 2.87038640 |
| 110 | negative regulation of blood coagulation (GO:0030195) | 2.87038640 |
| 111 | aromatic amino acid family catabolic process (GO:0009074) | 2.85026740 |
| 112 | positive regulation of cholesterol efflux (GO:0010875) | 2.83804654 |
| 113 | positive regulation of hormone metabolic process (GO:0032352) | 2.83390966 |
| 114 | glycolipid catabolic process (GO:0019377) | 2.83220212 |
| 115 | positive regulation of protein sumoylation (GO:0033235) | 2.82751469 |
| 116 | negative regulation of autophagy (GO:0010507) | 2.82391772 |
| 117 | vocalization behavior (GO:0071625) | 2.82352598 |
| 118 | cell proliferation involved in metanephros development (GO:0072203) | 2.80786743 |
| 119 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.80307664 |
| 120 | amino sugar catabolic process (GO:0046348) | 2.80060062 |
| 121 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.79979206 |
| 122 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.79954045 |
| 123 | histone H3-K9 modification (GO:0061647) | 2.77860851 |
| 124 | macrophage activation (GO:0042116) | 2.77632984 |
| 125 | regulation of hypersensitivity (GO:0002883) | 2.76896336 |
| 126 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.76413922 |
| 127 | regulation of plasminogen activation (GO:0010755) | 2.76064453 |
| 128 | response to pheromone (GO:0019236) | 2.75816996 |
| 129 | skeletal muscle organ development (GO:0060538) | 2.73566961 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 2.70962813 |
| 131 | sodium-independent organic anion transport (GO:0043252) | 2.70123330 |
| 132 | epithelial structure maintenance (GO:0010669) | 2.69706673 |
| 133 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.67775414 |
| 134 | C21-steroid hormone metabolic process (GO:0008207) | 2.67403654 |
| 135 | response to thyroid hormone (GO:0097066) | 2.66196067 |
| 136 | regulation of activation of Janus kinase activity (GO:0010533) | 2.65716853 |
| 137 | positive regulation of chemokine secretion (GO:0090197) | 2.65344850 |
| 138 | bile acid metabolic process (GO:0008206) | 2.64696036 |
| 139 | vitamin D metabolic process (GO:0042359) | 2.64548730 |
| 140 | positive regulation of sterol transport (GO:0032373) | 2.62974592 |
| 141 | positive regulation of cholesterol transport (GO:0032376) | 2.62974592 |
| 142 | positive thymic T cell selection (GO:0045059) | 2.61124910 |
| 143 | urea metabolic process (GO:0019627) | 2.60889643 |
| 144 | negative regulation of coagulation (GO:0050819) | 2.60599275 |
| 145 | somatic stem cell division (GO:0048103) | 2.59456012 |
| 146 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.59270663 |
| 147 | negative regulation of protein activation cascade (GO:2000258) | 2.59222560 |
| 148 | protein localization to cell surface (GO:0034394) | 2.59103818 |
| 149 | opsonization (GO:0008228) | 2.58874656 |
| 150 | negative regulation of interleukin-12 production (GO:0032695) | 2.58764854 |
| 151 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.58288666 |
| 152 | positive regulation of hemostasis (GO:1900048) | 2.56992072 |
| 153 | positive regulation of blood coagulation (GO:0030194) | 2.56992072 |
| 154 | triglyceride homeostasis (GO:0070328) | 2.56866708 |
| 155 | acylglycerol homeostasis (GO:0055090) | 2.56866708 |
| 156 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.56258858 |
| 157 | L-ascorbic acid metabolic process (GO:0019852) | 2.54722950 |
| 158 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.54556623 |
| 159 | neutrophil activation involved in immune response (GO:0002283) | 2.53691010 |
| 160 | negative regulation of lipase activity (GO:0060192) | 2.53325830 |
| 161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.53008420 |
| 162 | venous blood vessel morphogenesis (GO:0048845) | 2.52159947 |
| 163 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.52126773 |
| 164 | vitamin catabolic process (GO:0009111) | 2.48757041 |
| 165 | fat-soluble vitamin catabolic process (GO:0042363) | 2.48757041 |
| 166 | azole transport (GO:0045117) | 2.47811385 |
| 167 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.46626926 |
| 168 | opioid receptor signaling pathway (GO:0038003) | 2.44906517 |
| 169 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.40672523 |
| 170 | positive regulation of protein homooligomerization (GO:0032464) | 2.39324499 |
| 171 | developmental pigmentation (GO:0048066) | 2.38202876 |
| 172 | regulation of myelination (GO:0031641) | 2.35063510 |
| 173 | glycine transport (GO:0015816) | 2.33344004 |
| 174 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.31063062 |
| 175 | detection of chemical stimulus (GO:0009593) | 2.27460263 |
| 176 | head development (GO:0060322) | 2.25894555 |
| 177 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.25637160 |
| 178 | regulation of meiosis (GO:0040020) | 2.25623997 |
| 179 | lymphangiogenesis (GO:0001946) | 2.25381138 |
| 180 | drinking behavior (GO:0042756) | 2.24973087 |
| 181 | forebrain neuron differentiation (GO:0021879) | 2.24317629 |
| 182 | long term synaptic depression (GO:0060292) | 2.21011191 |
| 183 | cell proliferation involved in kidney development (GO:0072111) | 2.19573791 |
| 184 | negative regulation of phagocytosis (GO:0050765) | 2.18504157 |
| 185 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.17901261 |
| 186 | negative regulation of cell fate specification (GO:0009996) | 2.15754141 |
| 187 | regulation of glial cell proliferation (GO:0060251) | 2.14084696 |
| 188 | mesonephros development (GO:0001823) | 2.13548888 |
| 189 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.11785537 |
| 190 | regulation of transcription from RNA polymerase III promoter (GO:0006359) | 2.08513695 |
| 191 | arginine catabolic process (GO:0006527) | 2.06841666 |
| 192 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.03231527 |
| 193 | mRNA transcription (GO:0009299) | 2.03080353 |
| 194 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.01314863 |
| 195 | aminoglycoside antibiotic metabolic process (GO:0030647) | 16.1262940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.70913343 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.62577366 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.80193058 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36913098 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.22708992 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14727470 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.99680869 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.98398846 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.97488011 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76157335 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76157335 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70346462 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.67761922 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60429119 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60309331 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.58394148 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.56550920 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46406831 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.45439116 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43708188 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38685972 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.34302126 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26095991 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.23892363 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22985259 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.19492908 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17446795 |
| 28 | RXR_22108803_ChIP-Seq_LS180_Human | 2.16863521 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12907531 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08638078 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07967478 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02518043 |
| 33 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01167493 |
| 34 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00443984 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99818207 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94631169 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94515320 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90300935 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89744473 |
| 40 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86160454 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84658607 |
| 42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.82642468 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81800210 |
| 44 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.80097375 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79299976 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78452314 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78281470 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.77674109 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.76910765 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71453689 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.70600924 |
| 52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68253078 |
| 53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67204098 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65732544 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.62486030 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61182958 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60759510 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56049011 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51411324 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50699611 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48637519 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47216613 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41386088 |
| 64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40529532 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40052252 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37403649 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37084433 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34146176 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34079513 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33011222 |
| 71 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32744262 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30077704 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29649854 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28337146 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25256603 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24996939 |
| 77 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24181740 |
| 78 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24051104 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23332045 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22961063 |
| 81 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.22917230 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22871769 |
| 83 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.21772195 |
| 84 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.21772195 |
| 85 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.21772195 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21533090 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.20816986 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19329769 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19218526 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19126117 |
| 91 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18950912 |
| 92 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18913983 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17962742 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15671599 |
| 95 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15221105 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14851885 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14837875 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13819949 |
| 99 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13811568 |
| 100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13670458 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.13327308 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13169813 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12070034 |
| 104 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11972155 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11873448 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11708104 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11553019 |
| 108 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10305759 |
| 109 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10030362 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09919571 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09158255 |
| 112 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08986694 |
| 113 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07992216 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06616265 |
| 115 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06303568 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05208710 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04691019 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04478228 |
| 119 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.04428410 |
| 120 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04381808 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04206627 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03805862 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03503337 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01907164 |
| 125 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01680693 |
| 126 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00640189 |
| 127 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.00453497 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00176161 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99468397 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98486139 |
| 131 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98006477 |
| 132 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.97152417 |
| 133 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97052105 |
| 134 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96795784 |
| 135 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96645156 |
| 136 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96604577 |
| 137 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96353952 |
| 138 | STAT3_23295773_ChIP-Seq_U87_Human | 0.96179863 |
| 139 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95225513 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95115102 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94291682 |
| 142 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94249787 |
| 143 | JUN_21703547_ChIP-Seq_K562_Human | 0.93371545 |
| 144 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93012793 |
| 145 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92536481 |
| 146 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92371778 |
| 147 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92311614 |
| 148 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92311614 |
| 149 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92212551 |
| 150 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.91924908 |
| 151 | TBL1_22424771_ChIP-Seq_293T_Human | 0.91621062 |
| 152 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91503967 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90754697 |
| 154 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90741566 |
| 155 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.90199424 |
| 156 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90022066 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89717065 |
| 158 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89460405 |
| 159 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89150780 |
| 160 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88891110 |
| 161 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88802455 |
| 162 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88031476 |
| 163 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87905821 |
| 164 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.87703034 |
| 165 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87638136 |
| 166 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87231806 |
| 167 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86685419 |
| 168 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85692533 |
| 169 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85099486 |
| 170 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84723945 |
| 171 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84695791 |
| 172 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84620009 |
| 173 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83969069 |
| 174 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83916409 |
| 175 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83881055 |
| 176 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83847309 |
| 177 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82872039 |
| 178 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81866311 |
| 179 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81822555 |
| 180 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80960554 |
| 181 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80960554 |
| 182 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80733497 |
| 183 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79904457 |
| 184 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79314824 |
| 185 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.78461989 |
| 186 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.78292482 |
| 187 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.76154943 |
| 188 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74449756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005645_abnormal_hypothalamus_physiol | 5.20581950 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.13729707 |
| 3 | MP0000678_abnormal_parathyroid_gland | 4.88118611 |
| 4 | MP0005058_abnormal_lysosome_morphology | 4.54541475 |
| 5 | MP0009697_abnormal_copulation | 4.39061119 |
| 6 | MP0009840_abnormal_foam_cell | 4.02661037 |
| 7 | MP0005365_abnormal_bile_salt | 3.61535450 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.51675684 |
| 9 | MP0003195_calcinosis | 3.33220371 |
| 10 | MP0005360_urolithiasis | 2.81339524 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.77510734 |
| 12 | MP0003646_muscle_fatigue | 2.68027086 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.65842802 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.64936310 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.60577185 |
| 16 | MP0003941_abnormal_skin_development | 2.57209987 |
| 17 | MP0000604_amyloidosis | 2.38318311 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.36189991 |
| 19 | MP0003303_peritoneal_inflammation | 2.35780683 |
| 20 | MP0000566_synostosis | 2.30741879 |
| 21 | MP0005171_absent_coat_pigmentation | 2.29874125 |
| 22 | MP0006082_CNS_inflammation | 2.26614486 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.20775509 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.19172125 |
| 25 | MP0003436_decreased_susceptibility_to | 2.16778269 |
| 26 | MP0003724_increased_susceptibility_to | 2.03153721 |
| 27 | MP0008004_abnormal_stomach_pH | 10.3543149 |
| 28 | MP0009785_altered_susceptibility_to | 1.94115876 |
| 29 | MP0002419_abnormal_innate_immunity | 1.93477919 |
| 30 | MP0003045_fibrosis | 1.93136348 |
| 31 | MP0004858_abnormal_nervous_system | 1.87385766 |
| 32 | MP0004859_abnormal_synaptic_plasticity | 1.86448321 |
| 33 | MP0003690_abnormal_glial_cell | 1.86275101 |
| 34 | MP0002938_white_spotting | 1.80532259 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.80031202 |
| 36 | MP0005451_abnormal_body_composition | 1.74228752 |
| 37 | MP0005671_abnormal_response_to | 1.73584585 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.72972306 |
| 39 | MP0003252_abnormal_bile_duct | 1.71307654 |
| 40 | MP0005387_immune_system_phenotype | 1.66607674 |
| 41 | MP0001790_abnormal_immune_system | 1.66607674 |
| 42 | MP0001664_abnormal_digestion | 1.66058739 |
| 43 | MP0000685_abnormal_immune_system | 1.59978356 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.57791599 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.55604794 |
| 46 | MP0003880_abnormal_central_pattern | 1.54578660 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.53987374 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.53841603 |
| 49 | MP0005647_abnormal_sex_gland | 1.53840637 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.53595374 |
| 51 | MP0009046_muscle_twitch | 1.52782573 |
| 52 | MP0004043_abnormal_pH_regulation | 1.51787404 |
| 53 | MP0000343_altered_response_to | 1.51423724 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.49253764 |
| 55 | MP0003329_amyloid_beta_deposits | 1.48798160 |
| 56 | MP0005025_abnormal_response_to | 1.47206507 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.45800959 |
| 58 | MP0008469_abnormal_protein_level | 1.44800196 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.44133901 |
| 60 | MP0005000_abnormal_immune_tolerance | 1.43161723 |
| 61 | MP0005332_abnormal_amino_acid | 1.40288596 |
| 62 | MP0002132_abnormal_respiratory_system | 1.40253949 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.38850626 |
| 64 | MP0000470_abnormal_stomach_morphology | 1.38840382 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.37420640 |
| 66 | MP0008874_decreased_physiological_sensi | 1.35645156 |
| 67 | MP0000609_abnormal_liver_physiology | 1.35020798 |
| 68 | MP0001835_abnormal_antigen_presentation | 1.34832254 |
| 69 | MP0001661_extended_life_span | 1.34767733 |
| 70 | MP0004885_abnormal_endolymph | 1.32297234 |
| 71 | MP0000639_abnormal_adrenal_gland | 1.28469806 |
| 72 | MP0009764_decreased_sensitivity_to | 1.27854454 |
| 73 | MP0002796_impaired_skin_barrier | 1.27833035 |
| 74 | MP0001853_heart_inflammation | 1.27249435 |
| 75 | MP0004134_abnormal_chest_morphology | 1.27020227 |
| 76 | MP0004233_abnormal_muscle_weight | 1.23493837 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 1.23318603 |
| 78 | MP0003868_abnormal_feces_composition | 1.22618372 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 1.21899136 |
| 80 | MP0001293_anophthalmia | 1.20406277 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.19025063 |
| 82 | MP0001501_abnormal_sleep_pattern | 1.18840515 |
| 83 | MP0000681_abnormal_thyroid_gland | 1.18676114 |
| 84 | MP0003011_delayed_dark_adaptation | 1.18394284 |
| 85 | MP0002909_abnormal_adrenal_gland | 1.17928687 |
| 86 | MP0000516_abnormal_urinary_system | 1.17611481 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 1.17611481 |
| 88 | MP0002723_abnormal_immune_serum | 1.13799243 |
| 89 | MP0001968_abnormal_touch/_nociception | 1.12693281 |
| 90 | MP0002254_reproductive_system_inflammat | 1.11766596 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 1.11728897 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.11070528 |
| 93 | MP0002452_abnormal_antigen_presenting | 1.08937984 |
| 94 | MP0005248_abnormal_Harderian_gland | 1.07644876 |
| 95 | MP0005503_abnormal_tendon_morphology | 1.07082707 |
| 96 | MP0000920_abnormal_myelination | 1.05798138 |
| 97 | MP0010368_abnormal_lymphatic_system | 1.04199924 |
| 98 | MP0009745_abnormal_behavioral_response | 1.03240522 |
| 99 | MP0002090_abnormal_vision | 1.02765169 |
| 100 | MP0004510_myositis | 1.02720322 |
| 101 | MP0009643_abnormal_urine_homeostasis | 1.01650352 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.97105941 |
| 103 | * MP0002557_abnormal_social/conspecific_i | 0.96867001 |
| 104 | MP0002971_abnormal_brown_adipose | 0.96626622 |
| 105 | MP0005670_abnormal_white_adipose | 0.95158426 |
| 106 | MP0001800_abnormal_humoral_immune | 0.94669597 |
| 107 | MP0004947_skin_inflammation | 0.93448641 |
| 108 | MP0005083_abnormal_biliary_tract | 0.93440034 |
| 109 | * MP0003879_abnormal_hair_cell | 0.93318371 |
| 110 | MP0010329_abnormal_lipoprotein_level | 0.92510708 |
| 111 | MP0003279_aneurysm | 0.92189462 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.91943732 |
| 113 | MP0002064_seizures | 0.91133859 |
| 114 | MP0005257_abnormal_intraocular_pressure | 0.91058300 |
| 115 | MP0002075_abnormal_coat/hair_pigmentati | 0.90888121 |
| 116 | MP0002405_respiratory_system_inflammati | 0.89217394 |
| 117 | MP0005164_abnormal_response_to | 0.88939045 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88226685 |
| 119 | * MP0002572_abnormal_emotion/affect_behav | 0.86737154 |
| 120 | MP0003632_abnormal_nervous_system | 0.86512904 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.85917774 |
| 122 | MP0003936_abnormal_reproductive_system | 0.85462084 |
| 123 | MP0004085_abnormal_heartbeat | 0.85210352 |
| 124 | MP0001764_abnormal_homeostasis | 0.84903684 |
| 125 | MP0003385_abnormal_body_wall | 0.84306703 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.83494149 |
| 127 | MP0002933_joint_inflammation | 0.83390827 |
| 128 | MP0009763_increased_sensitivity_to | 0.82837615 |
| 129 | MP0003828_pulmonary_edema | 0.82051743 |
| 130 | MP0001819_abnormal_immune_cell | 0.81202735 |
| 131 | MP0003635_abnormal_synaptic_transmissio | 0.81085573 |
| 132 | MP0006138_congestive_heart_failure | 0.80895966 |
| 133 | MP0005501_abnormal_skin_physiology | 0.79948064 |
| 134 | MP0002420_abnormal_adaptive_immunity | 0.78771265 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.78752373 |
| 136 | MP0000858_altered_metastatic_potential | 0.78129236 |
| 137 | MP0010155_abnormal_intestine_physiology | 0.77401681 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.76830925 |
| 139 | MP0001919_abnormal_reproductive_system | 0.76593776 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.76370534 |
| 141 | MP0005389_reproductive_system_phenotype | 0.75922675 |
| 142 | MP0002102_abnormal_ear_morphology | 0.75810746 |
| 143 | MP0009115_abnormal_fat_cell | 0.75615982 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.75438995 |
| 145 | MP0000733_abnormal_muscle_development | 0.75333839 |
| 146 | MP0001756_abnormal_urination | 0.74964026 |
| 147 | * MP0001486_abnormal_startle_reflex | 0.74919728 |
| 148 | MP0003806_abnormal_nucleotide_metabolis | 0.74804712 |
| 149 | MP0004883_abnormal_blood_vessel | 0.73284077 |
| 150 | MP0010386_abnormal_urinary_bladder | 0.73199892 |
| 151 | MP0000249_abnormal_blood_vessel | 0.72915078 |
| 152 | MP0005397_hematopoietic_system_phenotyp | 0.72239239 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.72239239 |
| 154 | MP0003638_abnormal_response/metabolism_ | 0.72058568 |
| 155 | MP0005310_abnormal_salivary_gland | 0.71226495 |
| 156 | MP0002998_abnormal_bone_remodeling | 0.70412323 |
| 157 | MP0001502_abnormal_circadian_rhythm | 0.70036861 |
| 158 | MP0001346_abnormal_lacrimal_gland | 0.68987957 |
| 159 | MP0004185_abnormal_adipocyte_glucose | 0.68155814 |
| 160 | MP0005085_abnormal_gallbladder_physiolo | 0.66376902 |
| 161 | MP0001881_abnormal_mammary_gland | 0.65204049 |
| 162 | MP0008775_abnormal_heart_ventricle | 0.63608869 |
| 163 | MP0002638_abnormal_pupillary_reflex | 0.62869803 |
| 164 | MP0003938_abnormal_ear_development | 0.62556459 |
| 165 | MP0001970_abnormal_pain_threshold | 0.62097401 |
| 166 | MP0003795_abnormal_bone_structure | 0.61014693 |
| 167 | MP0009780_abnormal_chondrocyte_physiolo | 0.60740541 |
| 168 | MP0002067_abnormal_sensory_capabilities | 0.60166562 |
| 169 | MP0000372_irregular_coat_pigmentation | 0.59098977 |
| 170 | MP0003935_abnormal_craniofacial_develop | 0.58472263 |
| 171 | MP0004019_abnormal_vitamin_homeostasis | 0.57825528 |
| 172 | MP0000427_abnormal_hair_cycle | 0.55104720 |
| 173 | * MP0003878_abnormal_ear_physiology | 0.54953879 |
| 174 | * MP0005377_hearing/vestibular/ear_phenot | 0.54953879 |
| 175 | MP0002736_abnormal_nociception_after | 0.54820535 |
| 176 | MP0001186_pigmentation_phenotype | 0.53644314 |
| 177 | MP0002168_other_aberrant_phenotype | 0.53574676 |
| 178 | MP0002928_abnormal_bile_duct | 0.52740873 |
| 179 | MP0003075_altered_response_to | 0.51935716 |
| 180 | MP0002113_abnormal_skeleton_development | 0.51777758 |
| 181 | MP0008995_early_reproductive_senescence | 0.50792398 |
| 182 | MP0002127_abnormal_cardiovascular_syste | 0.49642153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Follicular hyperkeratosis (HP:0007502) | 9.31687503 |
| 2 | Complement deficiency (HP:0004431) | 7.89916705 |
| 3 | Glomerulonephritis (HP:0000099) | 7.88251428 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 7.73058237 |
| 5 | Absent eyelashes (HP:0000561) | 7.42412540 |
| 6 | Absent eyebrow (HP:0002223) | 7.31458271 |
| 7 | Recurrent corneal erosions (HP:0000495) | 6.62606442 |
| 8 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.61777750 |
| 9 | Absent/shortened dynein arms (HP:0200106) | 6.61777750 |
| 10 | Cheilitis (HP:0100825) | 6.39075659 |
| 11 | Chronic otitis media (HP:0000389) | 6.18315123 |
| 12 | Abnormality of complement system (HP:0005339) | 6.07895692 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 5.52068508 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.52068508 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.52068508 |
| 16 | Deep venous thrombosis (HP:0002625) | 5.23813111 |
| 17 | Hyperphosphatemia (HP:0002905) | 5.19496455 |
| 18 | Nephritis (HP:0000123) | 4.76912816 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 4.52366361 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 4.49022993 |
| 21 | Erythroderma (HP:0001019) | 4.44096662 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.32367630 |
| 23 | Dysostosis multiplex (HP:0000943) | 4.31291305 |
| 24 | Tetany (HP:0001281) | 4.25377259 |
| 25 | Renal dysplasia (HP:0000110) | 4.20260278 |
| 26 | Ectropion (HP:0000656) | 4.07455087 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 4.01366813 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90753598 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.84985531 |
| 30 | Abnormal ciliary motility (HP:0012262) | 3.84547270 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.83796290 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.83796290 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.83796290 |
| 34 | Absent hair (HP:0002298) | 3.83563670 |
| 35 | Xanthomatosis (HP:0000991) | 3.83219275 |
| 36 | Mucopolysacchariduria (HP:0008155) | 3.73936463 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.73936463 |
| 38 | Joint hemorrhage (HP:0005261) | 3.71004818 |
| 39 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.70086395 |
| 40 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.70086395 |
| 41 | Mitral stenosis (HP:0001718) | 3.55320765 |
| 42 | * Abnormality of dental color (HP:0011073) | 3.53120138 |
| 43 | Blepharitis (HP:0000498) | 3.51873334 |
| 44 | Chronic sinusitis (HP:0011109) | 3.48966815 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.46649292 |
| 46 | Retinal atrophy (HP:0001105) | 3.32096520 |
| 47 | Palmoplantar hyperkeratosis (HP:0000972) | 3.18639853 |
| 48 | Rhinitis (HP:0012384) | 3.15494572 |
| 49 | Optic neuritis (HP:0100653) | 3.15272269 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 3.15272269 |
| 51 | Orchitis (HP:0100796) | 3.13499544 |
| 52 | Loss of speech (HP:0002371) | 3.12786357 |
| 53 | Neoplasm of the lung (HP:0100526) | 3.06752180 |
| 54 | Neurofibrillary tangles (HP:0002185) | 3.02387771 |
| 55 | Abnormality of macrophages (HP:0004311) | 3.00974747 |
| 56 | Palmar hyperkeratosis (HP:0010765) | 2.99379653 |
| 57 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.95774326 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.95365967 |
| 59 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.94339880 |
| 60 | Purpura (HP:0000979) | 2.91693349 |
| 61 | Keratitis (HP:0000491) | 2.89997713 |
| 62 | Small epiphyses (HP:0010585) | 2.83180975 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.80328242 |
| 64 | Myocardial infarction (HP:0001658) | 2.79129206 |
| 65 | Nuclear cataract (HP:0100018) | 2.77766250 |
| 66 | Myositis (HP:0100614) | 2.76173363 |
| 67 | Vertebral arch anomaly (HP:0008438) | 2.75057465 |
| 68 | Amyloidosis (HP:0011034) | 2.74050453 |
| 69 | Plagiocephaly (HP:0001357) | 2.70984336 |
| 70 | Neoplasm of the respiratory system (HP:0100606) | 2.68253307 |
| 71 | Hypobetalipoproteinemia (HP:0003563) | 2.67632050 |
| 72 | Corneal erosion (HP:0200020) | 2.64788798 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.64522030 |
| 74 | Axonal loss (HP:0003447) | 2.62846150 |
| 75 | Disinhibition (HP:0000734) | 2.60300519 |
| 76 | Erythema (HP:0010783) | 2.54533415 |
| 77 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.52413985 |
| 78 | Urticaria (HP:0001025) | 2.51893425 |
| 79 | Rectal prolapse (HP:0002035) | 2.51146880 |
| 80 | Chronic hepatic failure (HP:0100626) | 2.47577584 |
| 81 | Mutism (HP:0002300) | 2.45822449 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.43135307 |
| 83 | Arthropathy (HP:0003040) | 2.39867498 |
| 84 | Pulmonary embolism (HP:0002204) | 2.34402596 |
| 85 | Plantar hyperkeratosis (HP:0007556) | 2.31867329 |
| 86 | Abnormal biliary tract physiology (HP:0012439) | 2.31366689 |
| 87 | Bile duct proliferation (HP:0001408) | 2.31366689 |
| 88 | Hyperactive renin-angiotensin system (HP:0000841) | 2.27453736 |
| 89 | Ulnar bowing (HP:0003031) | 2.26934779 |
| 90 | Hypolipoproteinemia (HP:0010981) | 2.26136086 |
| 91 | Hypoalphalipoproteinemia (HP:0003233) | 2.25260492 |
| 92 | Melanoma (HP:0002861) | 2.24119857 |
| 93 | Thrombophlebitis (HP:0004418) | 2.24034353 |
| 94 | Decreased circulating renin level (HP:0003351) | 2.20496500 |
| 95 | Eczematoid dermatitis (HP:0000976) | 2.20144674 |
| 96 | Metabolic alkalosis (HP:0200114) | 2.18926465 |
| 97 | Hypophosphatemia (HP:0002148) | 2.17403908 |
| 98 | Pathologic fracture (HP:0002756) | 2.15248587 |
| 99 | J-shaped sella turcica (HP:0002680) | 2.14718457 |
| 100 | Gingival bleeding (HP:0000225) | 2.14686350 |
| 101 | Coronal craniosynostosis (HP:0004440) | 2.13583109 |
| 102 | Sparse eyelashes (HP:0000653) | 2.11381380 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 2.09504987 |
| 104 | Joint swelling (HP:0001386) | 2.08565802 |
| 105 | Esophageal varix (HP:0002040) | 2.08230813 |
| 106 | Facial shape deformation (HP:0011334) | 2.08038491 |
| 107 | Potter facies (HP:0002009) | 2.08038491 |
| 108 | Hypercholesterolemia (HP:0003124) | 2.07330598 |
| 109 | Recurrent abscess formation (HP:0002722) | 2.05912029 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 2.05026455 |
| 111 | Hypohidrosis (HP:0000966) | 2.04828698 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.03274609 |
| 113 | Increased serum ferritin (HP:0003281) | 2.01234287 |
| 114 | Epidermoid cyst (HP:0200040) | 2.00722184 |
| 115 | Parakeratosis (HP:0001036) | 11.9177658 |
| 116 | Alopecia of scalp (HP:0002293) | 10.7818932 |
| 117 | Unilateral renal agenesis (HP:0000122) | 10.1751590 |
| 118 | Renal agenesis (HP:0000104) | 1.99764657 |
| 119 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99651401 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 1.98584238 |
| 121 | Congenital sensorineural hearing impairment (HP:0008527) | 1.97602705 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95474665 |
| 123 | Hypoparathyroidism (HP:0000829) | 1.95046156 |
| 124 | Absent epiphyses (HP:0010577) | 1.93727705 |
| 125 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.93727705 |
| 126 | Abnormality of the periventricular white matter (HP:0002518) | 1.92681608 |
| 127 | Prolonged neonatal jaundice (HP:0006579) | 1.87187375 |
| 128 | Osteomalacia (HP:0002749) | 1.87100969 |
| 129 | Spontaneous abortion (HP:0005268) | 1.86402306 |
| 130 | Peripheral demyelination (HP:0011096) | 1.85957171 |
| 131 | Lymphangioma (HP:0100764) | 1.85676490 |
| 132 | Autoimmune thrombocytopenia (HP:0001973) | 1.85336325 |
| 133 | Hyperaldosteronism (HP:0000859) | 1.85250427 |
| 134 | Progressive neurologic deterioration (HP:0002344) | 1.82895401 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.82841567 |
| 136 | Spontaneous hematomas (HP:0007420) | 1.81572358 |
| 137 | Hyperlipoproteinemia (HP:0010980) | 1.81553544 |
| 138 | Corneal dystrophy (HP:0001131) | 1.80087477 |
| 139 | Amelogenesis imperfecta (HP:0000705) | 1.79937883 |
| 140 | Epistaxis (HP:0000421) | 1.78597812 |
| 141 | Pulmonary infiltrates (HP:0002113) | 1.78211954 |
| 142 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.74315743 |
| 143 | Rickets (HP:0002748) | 1.73695477 |
| 144 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73316581 |
| 145 | Progressive visual loss (HP:0000529) | 1.72943922 |
| 146 | Fat malabsorption (HP:0002630) | 1.72499992 |
| 147 | Hydroxyprolinuria (HP:0003080) | 1.71963756 |
| 148 | Abnormality of proline metabolism (HP:0010907) | 1.71963756 |
| 149 | Beaking of vertebral bodies (HP:0004568) | 1.71860188 |
| 150 | Abnormality of renin-angiotensin system (HP:0000847) | 1.71355355 |
| 151 | Hemoptysis (HP:0002105) | 1.70478911 |
| 152 | Polyneuropathy (HP:0001271) | 1.69223964 |
| 153 | Septo-optic dysplasia (HP:0100842) | 1.68405824 |
| 154 | Recurrent bacterial skin infections (HP:0005406) | 1.68404491 |
| 155 | Mediastinal lymphadenopathy (HP:0100721) | 1.68369734 |
| 156 | Abnormality of incisor morphology (HP:0011063) | 1.68355577 |
| 157 | Ulnar claw (HP:0001178) | 1.67528878 |
| 158 | Abnormality of the renal collecting system (HP:0004742) | 1.66393351 |
| 159 | Neuronal loss in central nervous system (HP:0002529) | 1.66373472 |
| 160 | Metaphyseal irregularity (HP:0003025) | 1.66245047 |
| 161 | White forelock (HP:0002211) | 1.65886743 |
| 162 | Acne (HP:0001061) | 1.65688214 |
| 163 | Abnormality of chloride homeostasis (HP:0011422) | 1.65252296 |
| 164 | Vasculitis (HP:0002633) | 1.64751509 |
| 165 | Vertebral compression fractures (HP:0002953) | 1.64264149 |
| 166 | Ectopic kidney (HP:0000086) | 1.63847455 |
| 167 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.63525551 |
| 168 | Hypocalcemia (HP:0002901) | 1.62734183 |
| 169 | Vascular calcification (HP:0004934) | 1.62578161 |
| 170 | Gangrene (HP:0100758) | 1.62465882 |
| 171 | Hypergonadotropic hypogonadism (HP:0000815) | 1.59726384 |
| 172 | Flattened epiphyses (HP:0003071) | 1.59691339 |
| 173 | Patchy hypopigmentation of hair (HP:0011365) | 1.58968960 |
| 174 | Duplicated collecting system (HP:0000081) | 1.54647208 |
| 175 | Convex nasal ridge (HP:0000444) | 1.52841547 |
| 176 | Abnormality of carpal bone ossification (HP:0006257) | 1.52761798 |
| 177 | Cardiovascular calcification (HP:0011915) | 1.50768683 |
| 178 | Hypoglycemic seizures (HP:0002173) | 1.49762566 |
| 179 | Retinal detachment (HP:0000541) | 1.47317071 |
| 180 | Conjugated hyperbilirubinemia (HP:0002908) | 1.46987797 |
| 181 | Nail dystrophy (HP:0008404) | 1.44217401 |
| 182 | Malignant hyperthermia (HP:0002047) | 1.43962215 |
| 183 | Omphalocele (HP:0001539) | 1.43602039 |
| 184 | Aortic regurgitation (HP:0001659) | 1.42744243 |
| 185 | Lymphopenia (HP:0001888) | 1.40270259 |
| 186 | Vertebral clefting (HP:0008428) | 1.40256264 |
| 187 | Oligohydramnios (HP:0001562) | 1.39039901 |
| 188 | Hypoplasia of the iris (HP:0007676) | 1.35437416 |
| 189 | Cutaneous finger syndactyly (HP:0010554) | 1.30877758 |
| 190 | Neonatal hypoglycemia (HP:0001998) | 1.30076788 |
| 191 | Widely spaced teeth (HP:0000687) | 1.29929834 |
| 192 | Vesicoureteral reflux (HP:0000076) | 1.29620781 |
| 193 | Bowed forearm bones (HP:0003956) | 1.29612232 |
| 194 | Bowing of the arm (HP:0006488) | 1.29612232 |
| 195 | Split hand (HP:0001171) | 1.29612108 |
| 196 | Fetal akinesia sequence (HP:0001989) | 1.28773605 |
| 197 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.28271050 |
| 198 | Scapular winging (HP:0003691) | 1.27519597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK2 | 7.23744219 |
| 2 | SIK1 | 7.05725225 |
| 3 | MARK3 | 3.86031954 |
| 4 | EPHA2 | 3.39798982 |
| 5 | PAK4 | 2.97498639 |
| 6 | IRAK3 | 2.74672669 |
| 7 | BLK | 2.72948840 |
| 8 | LATS1 | 2.71732118 |
| 9 | ERN1 | 2.59148062 |
| 10 | TBK1 | 2.09687524 |
| 11 | FGFR4 | 2.02217861 |
| 12 | RIPK1 | 2.02078703 |
| 13 | SIK3 | 10.0571160 |
| 14 | TYK2 | 1.83856992 |
| 15 | MATK | 1.80116483 |
| 16 | JAK1 | 1.68131676 |
| 17 | MARK2 | 1.61567104 |
| 18 | LATS2 | 1.59833318 |
| 19 | STK38L | 1.50499923 |
| 20 | MAP2K6 | 1.48079824 |
| 21 | GRK7 | 1.44645202 |
| 22 | AKT3 | 1.43865069 |
| 23 | PRPF4B | 1.42858881 |
| 24 | IKBKB | 1.41792596 |
| 25 | MAP3K3 | 1.41222198 |
| 26 | WNK4 | 1.41067289 |
| 27 | CDK8 | 1.32616617 |
| 28 | WNK1 | 1.30410150 |
| 29 | ZAP70 | 1.28733868 |
| 30 | MAP3K12 | 1.28220408 |
| 31 | EPHA4 | 1.23295703 |
| 32 | TAOK3 | 1.20185190 |
| 33 | STK38 | 1.20169683 |
| 34 | CDC42BPA | 1.20070397 |
| 35 | BCKDK | 1.12568024 |
| 36 | NME1 | 1.11670386 |
| 37 | NME2 | 1.11484881 |
| 38 | PDPK1 | 1.10273081 |
| 39 | FGFR3 | 1.06271820 |
| 40 | IKBKE | 1.04298441 |
| 41 | BMPR2 | 1.03818614 |
| 42 | PDK1 | 1.01624750 |
| 43 | JAK3 | 0.99699367 |
| 44 | KDR | 0.99265489 |
| 45 | STK39 | 0.96862635 |
| 46 | MAP2K3 | 0.95598184 |
| 47 | ADRBK2 | 0.95585644 |
| 48 | JAK2 | 0.95178382 |
| 49 | CHUK | 0.89499597 |
| 50 | PDK2 | 0.88417163 |
| 51 | CAMK1 | 0.87321969 |
| 52 | TAOK1 | 0.86148627 |
| 53 | EPHA3 | 0.85349712 |
| 54 | CAMKK2 | 0.84664895 |
| 55 | TRPM7 | 0.82568841 |
| 56 | NTRK3 | 0.81733869 |
| 57 | CSNK1A1L | 0.78947108 |
| 58 | CSNK1D | 0.76763119 |
| 59 | SYK | 0.75386905 |
| 60 | ABL2 | 0.75130965 |
| 61 | ACVR1B | 0.70303775 |
| 62 | MAPK13 | 0.70185289 |
| 63 | OXSR1 | 0.69477404 |
| 64 | KIT | 0.69395392 |
| 65 | MAP2K4 | 0.68894375 |
| 66 | SGK2 | 0.68311335 |
| 67 | MOS | 0.66238236 |
| 68 | TYRO3 | 0.65889067 |
| 69 | TIE1 | 0.64180991 |
| 70 | EPHB1 | 0.64159833 |
| 71 | IGF1R | 0.63963016 |
| 72 | LCK | 0.63709615 |
| 73 | TNIK | 0.63563404 |
| 74 | MAP3K1 | 0.63008272 |
| 75 | CAMK4 | 0.57556077 |
| 76 | MST1R | 0.57296435 |
| 77 | SGK3 | 0.55372909 |
| 78 | GRK6 | 0.53557292 |
| 79 | PINK1 | 0.53197589 |
| 80 | IRAK1 | 0.52631763 |
| 81 | CSNK1G3 | 0.51892139 |
| 82 | CDK6 | 0.51715432 |
| 83 | EEF2K | 0.51020431 |
| 84 | TESK2 | 0.50077526 |
| 85 | PIM2 | 0.47993332 |
| 86 | PDGFRA | 0.47793693 |
| 87 | RET | 0.47765605 |
| 88 | IRAK4 | 0.46891853 |
| 89 | MAPK7 | 0.46578613 |
| 90 | MAP3K6 | 0.46182761 |
| 91 | NEK9 | 0.45879120 |
| 92 | ALK | 0.43477993 |
| 93 | DYRK1B | 0.43384672 |
| 94 | TAOK2 | 0.42571347 |
| 95 | SGK494 | 0.42165406 |
| 96 | SGK223 | 0.42165406 |
| 97 | STK3 | 0.41860679 |
| 98 | CDK7 | 0.41718139 |
| 99 | FGR | 0.40471231 |
| 100 | CSNK1G2 | 0.39855611 |
| 101 | PRKD3 | 0.39482825 |
| 102 | CSNK1G1 | 0.38893770 |
| 103 | TXK | 0.38856196 |
| 104 | TNK2 | 0.38736314 |
| 105 | PRKAA1 | 0.37781703 |
| 106 | MAP3K11 | 0.36742451 |
| 107 | MAPK11 | 0.36721844 |
| 108 | PRKAA2 | 0.33637891 |
| 109 | EPHB2 | 0.31500249 |
| 110 | FER | 0.31011190 |
| 111 | DAPK2 | 0.30779313 |
| 112 | BRD4 | 0.29283364 |
| 113 | RPS6KC1 | 0.28346095 |
| 114 | RPS6KL1 | 0.28346095 |
| 115 | RIPK4 | 0.28082542 |
| 116 | PRKG1 | 0.26236366 |
| 117 | MAP3K13 | 0.24898726 |
| 118 | SGK1 | 0.24607403 |
| 119 | MAP2K2 | 0.24082735 |
| 120 | MAP3K7 | 0.23997386 |
| 121 | INSR | 0.22076464 |
| 122 | PKN1 | 0.21359055 |
| 123 | CAMK1G | 0.21220882 |
| 124 | SRPK1 | 0.20560252 |
| 125 | MAP3K4 | 0.19551191 |
| 126 | RPS6KA6 | 0.19202986 |
| 127 | CDK4 | 0.18522717 |
| 128 | SRC | 0.17801004 |
| 129 | FES | 0.17349483 |
| 130 | FYN | 0.16633262 |
| 131 | ICK | 0.15967130 |
| 132 | CAMK1D | 0.13773441 |
| 133 | NTRK2 | 0.12713718 |
| 134 | INSRR | 0.11827679 |
| 135 | TTN | 0.11660994 |
| 136 | AKT1 | 0.11191950 |
| 137 | MET | 0.11138465 |
| 138 | DDR2 | 0.10662696 |
| 139 | BMX | 0.10295287 |
| 140 | PRKCQ | 0.08988780 |
| 141 | NTRK1 | 0.08464972 |
| 142 | PTK6 | 0.08459144 |
| 143 | CSK | 0.08059918 |
| 144 | PRKCH | 0.07610667 |
| 145 | TGFBR2 | 0.06845188 |
| 146 | TRIB3 | 0.06712839 |
| 147 | ERBB2 | 0.06704519 |
| 148 | MAP4K1 | 0.05866782 |
| 149 | HCK | 0.05010926 |
| 150 | CDK12 | 0.04354997 |
| 151 | MAPK12 | 0.04337725 |
| 152 | RPS6KA4 | 0.03933802 |
| 153 | LYN | 0.03329611 |
| 154 | MAP3K5 | 0.03270238 |
| 155 | CSF1R | 0.02639475 |
| 156 | CAMK2A | 0.02222994 |
| 157 | MAPK8 | 0.02083864 |
| 158 | PKN2 | 0.02069940 |
| 159 | STK10 | 0.01820442 |
| 160 | PTK2B | 0.01712080 |
| 161 | MAP3K14 | 0.01520722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mineral absorption_Homo sapiens_hsa04978 | 3.71894226 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.70270920 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21242671 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.79681663 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.77858554 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.46233058 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.44357434 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 2.37333305 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.22515867 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.07342867 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 2.06214469 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01511021 |
| 13 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.94920627 |
| 14 | Prion diseases_Homo sapiens_hsa05020 | 1.89339318 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81101679 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.77735470 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73167429 |
| 18 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.72294127 |
| 19 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.71757891 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71030731 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.70404109 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.65636706 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61051413 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.60134500 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55348403 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54941975 |
| 27 | Melanoma_Homo sapiens_hsa05218 | 1.54741768 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54538225 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51613076 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.50699085 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.45501666 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44540715 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42176891 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41021914 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39856315 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37839486 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33969192 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.33941205 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33008227 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.31064324 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30340095 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28257234 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27678127 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25933493 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.25212523 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.24597052 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.19250449 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18283539 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15834427 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14684379 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14289852 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12230939 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09028965 |
| 54 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.07868208 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06906724 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06229999 |
| 57 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05447638 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04860153 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04783498 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03688141 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03445871 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99346000 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97132069 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96852988 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.94006794 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.93829044 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91685461 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91043303 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89505645 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89319644 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.88662976 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88196297 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87603446 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87051816 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.86897129 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.85498381 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85477936 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84674458 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.84487310 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.84408631 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84181310 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83075796 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81175895 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81084207 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80249305 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80153190 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.79470194 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77569029 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76119141 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75471734 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.75151267 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.74316533 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73730352 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.73704070 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73067950 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72689250 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72321420 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71878063 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.70686183 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70061224 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67456039 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67259635 |
| 103 | Peroxisome_Homo sapiens_hsa04146 | 0.65880554 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65163625 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.64529524 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64011140 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63708763 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63519532 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63228457 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63226923 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62414861 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62306662 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60741901 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60701180 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59489645 |
| 116 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58792057 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57927573 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57726501 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57309949 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56207259 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56077767 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56058925 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55867534 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54453956 |
| 125 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54318695 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51539428 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.51174075 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50734114 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49840285 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49560795 |
| 131 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49492979 |
| 132 | Bile secretion_Homo sapiens_hsa04976 | 0.49284713 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49193034 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48788234 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.48726785 |
| 136 | Focal adhesion_Homo sapiens_hsa04510 | 0.48686389 |
| 137 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47998760 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47475068 |
| 139 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47384284 |
| 140 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47146423 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47057878 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46716913 |
| 143 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45935933 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45446471 |
| 145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44766871 |
| 146 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44656548 |
| 147 | ABC transporters_Homo sapiens_hsa02010 | 0.43784957 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.43637944 |
| 149 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43564214 |
| 150 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43452382 |
| 151 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42580622 |
| 152 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.41625957 |
| 153 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41604173 |
| 154 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41455379 |
| 155 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41392162 |
| 156 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41106032 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.41034845 |
| 158 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40901372 |
| 159 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40662021 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39106277 |
| 161 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38719230 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38096544 |
| 163 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38077788 |
| 164 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37994813 |
| 165 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37487021 |
| 166 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35101253 |
| 167 | Influenza A_Homo sapiens_hsa05164 | 0.34059422 |
| 168 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34018593 |
| 169 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31075359 |
| 170 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26029150 |

